Patent · US Active

Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile

US8101629B2 · kind B2 · utility

8Cited by

11References

21Claims

0Family size

Assignee

Janssen Pharmaceutica NA · BE

Inventors

Jérôme Emile Georges Guillemont · Andé, FR
Paul Theodoor Agnes Stevens · Turnhout, BE
Alex Herman Copmans · Beerse, BE
Jozef Peeters · Ieper, BE
Alfred Elisabeth Stappers · Oud-Turnhout, BE
Roger Petrus Gerebern Vandecruys · Westerlo, BE
Paul Stoffels · Hoogstraten, BE

Key dates

Filing date	Jul 28, 2010
Grant date	Jan 24, 2012
Priority date	—
Expiry date	Jul 28, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/2866
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a pharmaceutical composition comprising as active ingredient the hydrochloric acid salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethyl-phenyl]amino]-2-pyrimidinyl]amino]benzonitrile and to processes for their preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.